1. Probiotic Lactobacillus spp. act Against Helicobacter pylori-induced Inflammation
- Author
-
Wei Wei Chen, Wen Ling Yeh, Hsin-Chih Lai, Yu Hsin Lin, Wen-Wei Chang, Ya Hui Chen, Chih Ho Lai, Tzu Lung Lin, Hui Yu Wu, Yu Wen Chen, Tsai Wan Hua, Chen Yi Hsing, Chun Ya Chen, and Hui Ying Hsu
- Subjects
lcsh:Medicine ,Microbiology ,law.invention ,03 medical and health sciences ,Probiotic ,0302 clinical medicine ,Lactobacillus acidophilus ,Lactobacillus rhamnosus ,law ,Lactobacillus ,Medicine ,030304 developmental biology ,Bifidobacterium ,0303 health sciences ,biology ,Helicobacter pylori ,business.industry ,lcsh:R ,food and beverages ,Akkermansia ,General Medicine ,biology.organism_classification ,Multiple drug resistance ,inflammation ,030211 gastroenterology & hepatology ,business ,probiotic - Abstract
The bacterial species, Helicobacter pylori, is associated with several gastrointestinal diseases, and poses serious health threats owing to its resistance to antibiotics. Lactobacillus spp., on the other hand, possess probiotic activities that have beneficial effects in humans. However, the mechanisms by which Lactobacillus spp. harbor favorable functions and act against H. pylori infection remain to be explored. The aim of this study was to investigate the ability of bacterial strains, Lactobacillus rhamnosus and Lactobacillus acidophilus, termed GMNL-74 and GMNL-185, respectively, to inhibit H. pylori growth and inflammation. Our results showed that GMNL-74 and GMNL-185 possess potent antimicrobial activity against multidrug resistant (MDR)-H. pylori. In addition, an in vitro cell-based model revealed that the inhibition of H. pylori adhesion and invasion of gastric epithelial cells and interleukin-8 production were significantly decreased by treatment with both the Lactobacillus strains. In vivo studies demonstrated that colonization of H. pylori and induced inflammation in the mouse stomach were also alleviated by these Lactobacillus strains. Furthermore, the abundance of beneficial gut bacteria, including Bifidobacterium spp. and Akkermansia muciniphilia, were significantly increased in H. pylori-infected mice treated with GMNL-74 and GMNL-185. These results demonstrate that Lactobacillus spp. ameliorate H. pylori-induced inflammation and supports beneficial gut specific bacteria that act against H. pylori infection.
- Published
- 2019